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A STUDY ON SOLITARY THYROID NODULE
INTRODUCTION
Solitary thyroid nodule can be defined as a goitre which on clinical examination appears 
to be a single nodule in an otherwise normal thyroid gland1. Solitary thyroid nodule remains a 
common clinical problem.
Virtually any disease of the thyroid can present as a solitary nodule. A solitary nodule 
has  a  high  risk  of  being  malignant  (10-20%)  than  the  multiple  palpable  nodules  of  a 
multinodular goitre (5%).
A solitary nodule may become cosmetically distressing to a patient and occasionally 
causes pressure symptoms. Less frequently, an autonomously hyperfunctioning single nodule 
may cause hyperthyroidism. However, in the greater proportion of patients the major concern 
relates to the potential of malignancy with in such a nodule.
Until recently, many clinicians have advised and practiced the routine surgical resection 
of all solitary thyroid nodules for definitive histological assessment. Thyroid surgery, even in 
experienced hands is associated with definite morbidity and should not be undertaken lightly. It 
is  logical  to  propose  a  more  selective  surgical  policy  for  a  patient  with a  solitary  thyroid 
nodule, advising operation only for those individuals in whom cancer has been diagnosed or 
suspected or who are otherwise at risk of their goitre.
The incidence of thyroid cancer in patients with solitary thyroid nodule ranges from 11 
to 20% (Kendall & Condon, 1969) 20.
The  vast  majority  of  thyroid  nodules  are  benign  and  do  not  require  removal.  The 
physician or surgeon should be able to perform an accurate clinical assessment of any thyroid 
nodule, appreciate the risk factors for thyroid cancer, and be able to evaluate which patient 
would benefit from surgery.
Conservative management is appropriate when malignancy can be reasonably excluded.
AIM OF STUDY
1. To review the  data  regarding  the  prevalence  of  solitary  thyroid  nodule  and analyse  its 
distribution with respect to age, sex, etc.
2. Discussion of the clinical presentation and the significance of solitary thyroid nodule.
3. To evaluate the risk factors associated with occurrence of malignancy in a solitary nodule of 
thyroid.
4. To find out the percentage of malignancy in solitary nodule.
5. To study the clinicopatholgical correlation of solitary thyroid nodules
6. To study the correlation of FNAC and biopsy. To study the sensitivity and specificity of 
FNAC.
7. To  provide  a  clinically  applicable  and  cost-effective  approach  to  the  evaluation  and 
management of solitary thyroid nodule.
MATERIALS AND METHODS
This  is  a  prospective  study  of  randomly  selected  patients  with  clinically  palpable, 
solitary thyroid nodule diagnosed and treated at Coimbatore Medical College Hospital. Total 
duration of study was two years, from 2003 September to 2005 September.
Each patients Symptoms and signs were entered in a proforma (given at the end of this 
dissertation) with detailed clinical examination in relation to the thyroid swelling and lymph 
node involvement and a routine systemic and general examination was done.
All  patients  were  subjected  to  basic  investigations  like  complete  hemogram,  Blood 
sugar, Blood urea, serum cholesterol, urine analysis, chest radiogram and radiogram of neck. 
Tissue diagnosis was obtained by fine needle aspiration cytology in all the patients.
Thyroid profile was done in selected patients with features of hyper or hypofunctioning 
of  the  gland.  Radio  isotope scan  was not  done  since  the  facility  was  not  available  at  our 
hospital. Ultrasound of neck and Computed Tomogram scan of skull and chest were done in 
selected cases. All operated specimens were subjected to Histopathological examination.
Preoperative and postoperative complications were analysed. Most cases were regularly 
followed up throughout the study period. All the observations were analysed and compared 
with other studies.
SURGICAL ANATOMY
The  thyroid  gland  occupies  an  important  position  in  the  centre  of  the  visceral 
compartment of the neck, lying astride the trachea, just above the thoracic inlet. It normally 
weighs about 25 g.
The gland consists of two symmetrical lobes, united in front of the second, third and 
fourth tracheal rings by an isthmus of gland tissue. The extent of the gland is from the thyroid 
cartilage to the 5th or 6th tracheal ring or from C3 to T12.
Each lobe is pear shaped, consisting of a narrow upper pole and a broader lower pole. 
The right lobe is often larger than the left. The Thyroid gland is covered by fascia and the strap 
muscles,  and  more  laterally,  it  is  tucked  under  the  diverging  anterior  borders  of  the 
sternomastoid muscles and adjacent to the lobes on the medial side, is the carotid sheath.
Because  of  its  fascial  attachments,  the  gland moves  upwards  with  swallowing.  The 
normal gland is impalpable - though can be felt in thin necks. It is soft and supple and the 
tracheal rings can be palpated through it.
THE MUSCULO FASCIAL COVERINGS
The strap muscles are ensheathed by the general investing layer of cervical fascia, and 
this unites them in the midline.
These muscles are applied to the anterior surface of the gland, but separated from it, by a 
loose condensation of fascia derived from the pretracheal fascia. This false capsule covers the 
gland which is enclosed by its diaphonous true capsule with its very rich blood supply, clearly 
visible just beneath its surface. The pretracheal fascia is attached above to the thyroid cartilage 
and cricoid cartilage and this suspension of the gland from the larynx is responsible for its 
movement with deglutition.
In the surgical approach to the thyroid gland, the musculo fascial envelope is incised 
down the midline, which is relatively avascular, and the space between the two capsules of the 
gland is entered. This loose plane is easily developed and the gland exposed by retracting the 
strap muscles.
The  nerve  supply  of  these  muscles,  the  sternohyoid  and sternothyroid,  comes  from 
Cervical roots 1, 2 and 3 via branches from the ansa cervicalis. This branches enter the muscle 
at its lateral border and on the deep surface and the muscles may be divided transversely to 
facilitate access to the gland, provided they are resutured,  there does not appear to be any 
impairment of function.
The other important implication of the musculofascial covering of the gland is that at the 
end of thyroid operations, the divided fascial envelope is resutured in the midline and this again 
closes  the  visceral  space.  If  there  is  post  operative  haemorrhage  into  this  closed  space, 
respiratory embarrassment from tracheal compression results and requires release of sutures to 
restore the airway.
BLOOD SUPPLY
Superior thyroid artery is the first branch from the anterior aspect of the external  carotid 
artery,  after  giving  off  its  sternomastoid  and  superior  laryngeal branches, pierces the 
pretracheal fascia as a single vessel to reach the summit of the upper pole. It divides on the 
gland into an anterior branch that runs down to the isthmus and a posterior branch that runs 
down the back of the lobe and anastomoses with an ascending branch of the inferior thyroid 
artery from the lower pole.
The inferior thyroid artery, arises from the thyrocervical trunk, and passes behind the 
carotid sheath, and then runs transversely across the space between this and the Thyroid gland 
to enter the deep surface of the gland as several separate branches close to the tracheothyroid 
groove.
The recurrent  laryngeal  nerve lies  normally  behind  this  branches  or  may be related 
anteriorly or posteriorily to the branches.
The Thyroideima artery enters the lower part of the isthmus in 3 percent of individuals. 
It springs from the branchiocephalic trunk (or) direct from the arch of aorta.
The venous return from the upper pole follows superior thyroid artery. This superior thyroid 
vein, enters either internal jugular vein (or) common facial vein.
The middle thyroid vein, short and wide, passes from the middle of the lobe, directly 
into the internal jugular vein.
        From the isthmus and lower poles the inferior thyroid veins form a plexus that lies in 
the  pretracheal  fascia,  in  front  of  the  cervical  part  of  the  trachea  and  drain  into  the 
brachiocephalic veins.
LYMPHATIC DRAINAGE
The lymphatics follow the arteries. From the upper pole, they enter the antero superior 
group of deep cervical lymph nodes. From the lower pole, they pass with the inferior thyroid 
artery  back  to  its  point  of  origin  from the  subclavian  behind  the  carotid  sheath,  into  the 
posteroinferior group. A few pass downwards into pretracheal nodes, following the course of 
thyroidea ima artery.
NERVE SUPPLY
The gland receives its innervation from the sympathetic and parasympathetic divisions 
of the autonomic nervous system. The sympathetic fibres arise from the cervical ganglion and 
enter with blood vessels and are vasomotor in action. While the parasympathetic fibres are 
derived from the vagus and reach the gland via branches of the vagus and reach the gland via 
branches of the laryngeal nerves26.
The Thyroid gland’s relation to the recurrent laryngeal Nerve and to the external branch 
of superior laryngeal nerve is of major surgical significance.
Hunt reported the anatomy of recurrent laryngeal nerve in 100 cases. The right recurrent 
laryngeal nerve resided in the tracheoesophageal groove in 64% of cases, whereas the left nerve 
was similarly located in the left side in 77% of cases. 
The nerve was lateral to the trachea in 33% of cases on the right side and 22% on the left side. 
On one occasion on the right side, a direct recurrent laryngeal nerve was given off in the neck 
without looping around the subclavian artery. Sometimes the nerves can run anterolateral to 
trachea (Tr. 8%, Lt 6%), with a maximum risk of injury during surgery.
The inferior thyroid artery is often used as a landmark for demonstration of recurrent 
laryngeal nerve.  In most  of the cases,  the recurrent  laryngeal nerve passes posterior  to  the 
inferior thyroid artery or its branches. (60% of cases), in about 30% of cases, the nerves pass 
anterior to the artery and the rest, between the branches of the artery.
In 50% of cases, the nerve is embedded in the ligament of Beny, which is of importance, 
because traction on the gland will  put  the nerve on stretch and make it  subject  to section. 
Damage  to  the  recurrent  laryngeal  nerve  results  in  paresis  or  paralysis  of  the  intrinsic 
musculature of the larynx on that side which results in vocal cord paralysis.
The non recurrent laryngeal nerves occurs in 1% of cases and almost invariably on the 
right  side;  the  nerve from the  vagus,  runs  directly  to  the  gland along the  superior  thyroid 
pedicle, and may be at a risk, when this is transected.
The superior laryngeal nerves arises from the vagus, near the base of the skull, runs 
medial to carotid sheath, divides at the level of hyoid bone into external (muscular) and internal 
(sensory) branches.
External branch of superior laryngeal nerve innervates the cricothyroid muscle which is 
a tensor of the vocal cord. In most cases the superior laryngeal nerve lies adjacent to the 
vascular pedicles of the superior poles of the Thyroid gland, requiring that the vessels to be 
ligated with care to avoid injury, which are individually ligated and divided low on the gland, 
dissected laterally to the cricothyroid muscle.
HISTOLOGY OF THYROID GLAND
The thyroid  gland  is  enclosed  by  a  dense  connective  tissue  capsule.  The  lobes  are 
divided into multiple lobules formed of follicles variable in size and shape. There is an average 
of about 3 x 106 follicles in each gland, each measuring 30 micro m. Within the follicles is the 
clear  viscid  colloid.  The  follicles  are  lined  by  flattened  cuboidal  or  columnar  epithelium 
depending on glandular activity. Sparsely intermingled between the follicular cells and also 
within the interfollicular spaces are the parafollicular cells (the calcitonin secreting C cells). 
They are slightly larger than the follicular cells and have large nuclei and cytoplasmic granules. 
They  are  located  in  the  upper  poles  of  the  thyroid  lobes,  reflecting  their  origin  as 
neuroectodermal cells derived from the ultimobranchial bodies and part of the APUD series. 
The follicles are supported by a heavily vascularised connective tissue frame work.
EMBRYOLOGY
The Thyroid develops as an endodermal tubular structure from the posterior aspect of the fetal 
tongue, and grows downwards in front of the developing hyoid and larynx, bifurcating and fusing with 
growth elements from the 4th branchial pouch. The stem of the down growth forms the thyroglossal 
duct whose upper end remains as the foramen caecum of the tongue; the lower end forms the pyramidal 
lobe of the thyroid. Thyroglossal duct usually atrophies but may remain in whole or in part and produce 
abnormalities  in  later  life.  The  transient  ultimobranchial  pouches  (part  of  4th)  contribute  to  the 
development of thyroid, an element which becomes parafollicular (Calcitonin Secreting) cells. It is a 
matter of surgical importance that the 4th branchial pouches also produce the superior parathyroids 
which  maintain  close  relationship  to  the  superormedial  aspect  of  thyroid  lobes.  The  inferior 
parathyroids develop from 3rd branchial pouches and their relationship is more to thymus than thyroid. 
They normally come to lie between  the apex of the thymus and the lower pole of the thyroid or along 
the fibrous band, the thyrothymic ligament which unites them.
PHYSIOLOGY
Iodine Metabolism
The average daily requirement of Iodine is 0.1 mg. Iodine is converted to iodide in the 
stomach and duodenum and after absorption, distributed uniformly, actively transported into 
the thyroid, by an ATP - dependent process. The normal serum - thyroid 12 - ratio is about 1:5. 
But can be as high as 1:500.
Thyroid hormones T3  and T4  are bound to thyroglobulin within the colloid. Synthesis 
within the thyroglobulin complex is controlled by several enzymes in distinct steps.
(i) Trapping of inorganic iodide
ii) Oxidation of iodide to iodine
iii) Binding of iodine with tyrosine to form iodotyronine
iv) Coupling of monoiodtyronines and diodotyronines to form T3 and T4, rT3.
All the steps are accelerated by TSH acting through a specific membrane receptor, via 
the cAMP second messenger system. The coupling and oxidation of iodide are catalysed by a 
peroxidase enzyme, in the presence of H2O2.
When hormones are required the complex is reabsorbed in to the cell by endocytosis and 
thyroglobulin broken down by lysosomal action. This results in formation of T3, T4, rT3, MIT & 
DIT; the MIT & DIT are deiodinated and 12 reused T3  & T4  enter  the circulation and are 
transported  bound  to  thyroxine  binding  globulin  (TBG),  thyroxine  binding  pre-albumin 
(TBPA) and albumin. About 99.98% of hormones are protein bound.
The circulating plasma levels of T3-T4  are in a ratio of 1:20, but T3  is  less protein - 
bound, So is the more potent hormone, with a half life of 1 day compared to about 7 days for 
T4. T3  is the more important physiological harmone. Approximately 85% of T3  is produced by 
mono-deiodination of T4 in other tissues such as liver, muscle and Kidney.
Pituarty Thyroid Axis
Synthesis  and  liberation  of  thyroid  hormones  is  controlled  by  TSH  from  anterior 
pituitary.  Secretion  of  TSH  depends  on  the  level  of  circulating  thyroid  hormones  and  is 
modified in a classical negative feed back manner. Regulation of TSH secretion also results 
from the action of thyrotropin releasing hormone (TRH) produced in the hypothalamus.
Action of Thyroid Hormones
Thyroid hormones influence and speed up many metabolic processes in the body.
They are essential for normal growth, mental development and sexual maturation.
They also increase the sensitivity of the cardiovascular and central nervous systems to 
catecholamines  and  so  influence  cardiac  output  and  heart  rate.  many  of  these  actions  are 
mediated by T3  which by binding to specific receptors in cell nuclei alters the expression of 
some genes.
The  thyroid  hormones  are  deiodinated  and  the  rest  are  excreted  as  glucoronide 
conjugates.
Thyroid Function Tests
There are variety of tests available to assess the function of thyroid. No single test is 
diagnostic and therefore a combination of tests are indicated.
1. Measurement of Thyroid hormones in the serum
Total T4 and T3 represents total protein bound T4 an T3 and are not measurements of free 
active thyroid hormones. Total T4 and T3 are influenced by the thyroxine binding proteins in the 
serum. False high levels are seen in pregnancy and those who are taking oral contraceptive 
pills. False low values are seen in hypoproteinaemic states such as nephrotic syndrome. Drugs 
such as salicylates, penicillin compete with T3  and T4  for protein binding. So measurements of 
free T3 and T4 by Radioimmunoassay is specific.
FT4  measurement  helps  in  detecting  early  toxicity,  when  TT4  levels  are  normal.  In 
patients with end-organ resistance to T4  (Refetoffs sndrome). T4 levels are raised, but TSH 
levels are usually normal. T3 levels may be low in patients with reduced peripheral conversion 
of  T4  to  T3  due  to  starvation  (low  T3  syndrome)  or  due  to  drugs  (eg.  Propranolol).  T3 
thyrotoxicosis is a rare condition, in which levels of TT4 in the hyperthyroid patient are normal 
and RATU is normal, but TT3 levels are raised. It is seen in patients with endemic goitres and 
small solitary thyroid nodules.
2. Serum Protein Bound Iodine (PBI)
Normal range  3-5.8  mg/ 100 ml. It lacks specificity in that it measures non hormonal 
forms of iodine in the blood. False positive results are seen in
pregnancy,  persons  taking  iodides,  expectorants  containing  potassium  iodide  and  in  those 
taking oral contraceptive pills.
T3 Resin uptake:
Patients  serum is  incubated  with  radioactive  T3  so  that  the  latter  becomes  fixed  to 
unoccupied sites of Thyroid binding globulin. Naturally in hypethyrodism the unoccupied sites 
are low and in hypothyroidism the unoccupied sites are high. Then a secondary binder, a resin 
is added to the system, Resin uptake of T3 is more in thyrotoxicosis and low in hypothyroidism. 
The test serves as indirect measurements of unbound T4. From this free Thyroxin index can be 
calculated.
Free Thyroxine Index = Serum T4 x T3 uptake %26.
Measurement of Serum TSII:
Normal range is upto 0.15-4.2 micro u/mi. Levels over 40 micro u/mi are present in 
gross  thyroid  deficiency.  The  test  is  invaluable  in  the  early  detection  of  mild  degrees  of 
hypothyroidism seen after surgery for thyrotoxicosis or after radioiodine. Old RIA methods 
have been replaced with more sophisticated immunometric assays using monoclonal antibodies 
that target two separate sites on TSH molecule allowing reading with an accuracy down to 
0.005  micro  u/mi.  Estimation  of  these  low  concentrations  aids  the  distinction  of 
hyperthryoidism from euthyroidism.
TRH Test
When thyroid hormones are high as in hyperthyroidism, TSH is suppressed and I.V. 
Injection of TRH does not result in rise of TSH. When thyroid hormones are normal or low, 
TRH injection increases TSH level. Serum TSH is estimated at the beginning of the test and 
again 20 minutes and 60 minutes after injection of 200 micro gram of TRR. In euthyroid TSH 
level increases just above the basal level. In hypothyroidism there is an exaggerated response. 
This test is infrequently used but it is useful if thyroid hormones and TSH levels are discrepant, 
in Grave’ diseases, hypothyroidism due to pituitary or hypothalamic disease.
Radioactive Iodine Uptake Test (RAIU)
RAIU indicate rate of thyroid hormone synthesis and release.  5-25  mci of radioiodine 
1231 is given orally. Then after 24 hours thyroid content of 1231 is measured by a counter. It is 
measured after 24 hrs because it is convenient to the patient and also the value at 24 hrs is 
usually near its plateau. But in very severe hyperthyroidism measurement is taken earlier since 
the uptake and release is rapid.
Increased RAIU
Inference is increased hormone synthesis, causes
i) Hyperthyroidism (except T3 toxicosis and increased body iodide)
ii)  Ablation in hormones synthesis e.g. ineffectively or inefficiently used iodine.
iii) Acute or chronic iodine deficiency.
iv) Withdrawal of  factors  that  lead to thyroid hormone depletion e.g.  withdrawal of 
antithyroid  drugs,  recovery  from  subacute  thyroiditis,  withdrawal  of  exogenous 
hormones.
v) Compensatory  increase  in  hormone  synthesis  after  hormone  loss  e.g.  Nephrosis, 
chronic diarrhoea, soya bean ingestion.
Decreased RAIU:
i) Hypothyroidism
ii) Antithyroid agents
iii) Primary biosynthetic defects of hormone
v) Hashimoto’s disease
v) Subacute thyroiditis
vi) Increased availability of iodine
vi) Very severe hyperthyroidism due to increased release.
PATHOLOGY
A single palpable nodule in otherwise impalpable thyroid gland is called solitary nodule 
of thyroid. A single discrete nodule in a palpable thyroid gland is called dominant nodule1.
The problem of solitary nodule of thyroid is that about 10-20 % of solitary nodule of 
thyroid is malignant and the physical signs of malignancy may not be evident in thyroid as 
noticed elsewhere.
Formation of nodules
A  loss  of  co-ordination  between  iodine  metabolism,.  epithelial  multiplication, 
thyroglobulin synthesis and coiloid endocytosis are important in the genesis of nodule.
Iodine  deficiency  and  ingestion  of  goitrogens  are  the  commonest  cause  of  goitre 
formation.  Iodine  deficiency  or  goitrogens  or  hereditary  factors  lead  to  decrease  in  serum 
thyroid hormones with followed by increase in TSH which will produce diffuse hyperplastic 
goitre. The patient will become euthyroid because of normal thyroid hormone level, TSH level 
drops down and goitre disappears. If it persists after that it is a colloid goitre with inactive 
follicles.  Because of fluctuation in TSH level,  and varied response of cells to TSH, mixed 
active  and  inactive  follicles  are  formed.  In  active  follicles,  because  of  high  vascularity 
haemorrhage occurs with central necrosis. Growth stimulating antibodies are also responsible 
for  multinodular  goitre.  Patient  is  usually  euthyroid.  Firm  painless  nodules  are  palpable; 
hardness  may  be  due  to  calcification.  Pain  and  sudden  increase  in  size  may  be  due  to 
haemorrhage and simulate malignancy. Many thyroid disorders,  both benign and malignant 
may manifest as solitary nodule31.
CAUSES OF SOLITARY NODULE
A. CYST
Simple
Mixed - Cystic and Solid or Complex
B. PALPABLE NODULE OF TRUE MULTINODULAR GOITRE 
C. THYROIDITIS .
Hashimoto’s
Sub acute
D. Th4FECTION
Granulomatous disease
Abscess
E. ADENOMA - 30%
F. TOXIC ADENOMA
G. MALIGNANCY
Carcinoma - Primary * Differentiated
- Papillary
- Follicular
- Medullary thyroid carcinoma
* Undifferentiated
- Anaplastic
- Metastatic
Lymphoma
Clinically palpable nodule of a multinodular goitre is the most common cause of solitary 
nodule thyroid.
ADENOMA
Virtually all adenomas of thyroid present as a small discrete solitary nodule.
They occur most commonly in young and middle aged women. They rarely exceed 3 
cm. Almost all adenomas are of follicular variety. Rare types are papillary cystadenoma and 
Hurthle cell adenoma.
The  Differentiation  of  a  nodule  within  a  multinodular  goitre  from  an  adenoma  is 
difficult not only clinically but also anatomically.
The morphologic criteria used to identify adenoma are.
1. Complete fibrous encapsulation.
2. A clear distinction between the architecture inside and outside the capsule.
3. Compression of the thyroid parenchyma around the adenoma.
4. Lack of multinodularity in the remaining gland.
Histological classification of Adenoma
Type-I
A. Embiyonal Adenoma
The follicles are premature, very cellular and arranged in the form of cords.
B. Fetal Adenoma
Small follicles are arranged closely packed with a abundant connective tissue stroma.
C. SIMPLE ADENOMA
Composed of closely packed follicles of normal size.
D. Colloid Adenoma
Contains dilated follicles filled with colloid.
E. Hurthle Cell Adenoma
Composed  of  large  granular  cells  identical  to  those  encountered  in  various  non  - 
neoplastic thyroid lesions usually arranged in trabecular pattern.
Type II
A. Microfollicular
B. Macrofollicular
C. Atypical adenoma
Exhibits nuclear atypia, variability in cell morphology, including the presence of spindle 
shaped cells.
Follicular  adenoma  are  differentiated  from  follicular  carcinoma  by  the  absence  of 
capsular  or  vascular  invasion.  Thus  careful  sampling  of  capsule  is  required  to  exclude 
carcinoma.
Adenomas attain certain size and remain in that because the expansile pressure restricts 
blood supply. It may suddenly enlarge and may be painful because of haemorrhage within the 
nodule.  Adenomas  occasionally  have  some  dependence  on  TSH,  so  it  regresses  after 
administration of thyroid hormones.
Adenomatous goitre
Adenomatous goitre is usually multinodular but a few may present as solitary nodule. 
Most patients are euthyroid. Whether single or numerous, adenomatous nodules have similar 
appearances.
Typical features include
1. Nodularity created by islands of colloid filled or hyperplastic follicles.
2. Random irregular scarring.
3. Focal haemorrhages and haemosiderin deposition.
4. Focal calcification in areas of scarring
5. Microcyst formation.
Microscopically adenomatous nodules are composed of follicles of vaiying size. Some 
follicles are distended with colloid and lined by flattened epithelium, where as others are small 
and are more active appearing.
CARCINOMA
Papillary Carcinoma: (70%)
Common  in  adults  and  children.  Responsible  for  30%  of  the  thyroid  carcinoma 
occurring below 40 yrs.  More common in women.  It  grows slowly.  Metastasis  to  cervical 
lymphnodes are common. About 10-20% may present as only cervical lymphnode metastates. 
The primary is occult (lateral abelTant thyroid). All the lesions below 1.0 cm are called 
as occult or micro carcinoma. Blood spread is unusual. Prognosis is good. 10 year survival rate 
is about 70-80%.
Histology
Complicated  branching  tree  like  pattern  of  cells  outlined  by  papilliferous  axial 
fibrovascular stroma. Pale, empty nuclei (Orphan Annie eyed nuclei) and Psammoma bodies 
are present. Papillary carcinoma is subjected to the influence of pituitary T.S.H.
Follicular carcinoma (25%)
It is a well differentiated carcinoma of the thyroid but more aggressive than papillary 
carcinoma. More common in women. Peak incidence occurs in 5th and 6th decade.
Two types:
i) Encapsulated - less common
ii) Invasive mass
Haemorrhages, cystic degeneration and necrosis are common. Microscopically picture is 
that of adeno carcinoma with considerable range in size and differentiation of glands. Blood 
spread occurs in 70% cases. Commonest sites are lungs, bones, brain etc. Regional lymphnodes 
are involved in only 5% of cases.
Medullary carcinoma
Derived from parafollicular cells (C cells). It is an APUDOMA. 80% occur sporadically 
usually in adults. 10-20% occur in children and teenagers with associated syndromes.
MEN Ila : MTC, Phaechromocytomas, parathyroid tumours
MEN lIb: MTC,  Phaechromocytomas  +  Mucosal  neuroma,  Marfanoid  features, 
ganglioneuromatosis.
90% of the patients secrete calcitonin. Less frequently histamine, prostaglandins, ACTH 
and serotonin are secreted. It may present as a single nodule
or multiple nodules.  Sporadic forms occur in 5th  -  6th decades.  Often present in advanced 
forms. Familial type presents in second decade. Associated endocrine abnormalities bring the 
patient early. Diarrhoea is present in upto 30% of patients. Metastasis is usually to regional 
nodes (50%), lung, liver and bone. Medullaiy carcinoma is not TSH dependent. It does not take 
up  radio  iodine.  Diagnosis  of  medullary  carcinoma can  be  made  by  stimulating  calcitonin 
secretion by Pentagastrin and calcium infusions.
Anaplastic carcinoma
Usually occurs in 7th and 8th decades of life, it is a rapidly growing, locally infiltrative 
tumour with very poor prognosis.
              It spreads by lymphatics and by blood stream. Two histological types are small 
cell carcinoma and giant cell carcinoma. 1 year survival is about 20%.
Other  tumours  like  lymphoma,  sarcoma  and  secondaries  also  occur  in  thyroid. 
Secondary tumours usually arise from kidney, breast, colon, melanomas.
Thyroiditis
(i) Hashimoto’s Thyroditis
It is a an autoimmune thyroiditis. It is the commonest cause for goitrous hypothyroidism 
in places where iodine intake is adequate. It is a major cause for nonendemic goitre in children. 
The  goitre  is  due  to  thyroid  growth  immunglobulins  like  auto  antibodies  to  thyrotrophin 
receptors,  follicular microsomes,  thyroglobulin.  Thyroid parenchyma is  replaced by fibrous 
tissue because of the infiltration by lymphoid cells. So eventually hypothyroidism develops. 
Sometimes in the midcourse patient may develop thyrotoxicosis called ‘Hasitoxicosis’. More 
common in women at menopausal age. Usually both the lobes are involved. Nevertheless one 
lobe is larger than the other. It is lobulate and rubbery in consistency. It may be associated with 
pernicious anaemia, vitiligo, Rheumatoid arthritis etc.
Histology
Excessive  replacement  of  parenchyma  by  lymphocytes,  plasma  cells,  macrophages, 
lymphoid  germinal  centers.  Follicular  cells  are  transformed  into  eosinophilic  granular 
cystoplasmic cells called Hurthle cells (or oncocytes or Askanazy cells). Diagnosis rests on 
measurement of serum auto antibodies by Radio Immuno Assay. It is positive in over 85% of 
cases. Lymphoma may develop in Hashimoto’s thyroiditis.
(ii) Subacute Thyroiditis (De Quervain’s Thyroiditis)
Causative agent is a virus, probably mumps virus. Patient has flu like illness followed 
by pain and rapid onset of swelling of thyroid. Swelling may be diffuse or asymimetrical, and 
tender on palpation. During active phase patient may develop hyperthyroidism, then due to 
extensive destruction hypothyroidism develops30.
Histology:
Aggregation  of  macrophages  admixed  with  multi  nucleated  giant  cells;  It  is  a  self 
limiting condition.
Acute bacterial thyroiditis is rare. Commonest organisms are staphylococcus.
(iii) Riedel’s Thyroiditis (Lignious Thyroiditis).
Aetiology is unknown. There is extensive fibrosing reaction that destroys more or less 
all  the thyroid gland. The fibrous tissue may extend beyond the capsule and involve other 
structures in the neck. More common in females.
It  is  characterised  by  painless  enlargement  of  thyroid,  woody  hard  in  consistency, 
asymmetrical, pressure symptoms may be present especially tracheal compression. It may be 
associated  with  retropentoneal  fibrosis.  Occasionally  it  may  be  associated  with  sclerosing 
cholangitis. About 25-50% of the patients are hypothyroid.
Toxic Adenoma:
This  type  produces  hormones  in  sufficient  quantity  to  give  rise  to  hyperthyroidism. 
Thyroxine output is not controlled by TSH or LATS. It is an autonomous tumour. Patient has 
increased metabolic rate, loss of weight, intolerance to heat, tremors, fibrillations. Usually there 
is no exophthalmos. Radioiodine scan shows it to be a hot nodule.
Thyroid Cyst:
30% of Clinically palpable swellings are cystic.
Causes:
i) Colloid degeneration (50%)
ii) Degeneration of follicular adenoma
iii) 10-15% are malignant.
CLINICAL PRESENTATION
Patients with solitary nodule in thyroid may present for:
• Toxic symptoms (autonomous, hyper functioning nodule).
• Pressure symptoms - dyspnoea, dysphagia, hoarseness of voice and rarely superior 
venacaval obstruction.
• Metastatic disease in the neck lymph nodes
• Distant metastasis.
• Cosmetic reasons.
CLINICAL RISK FACTORS
Age
The risk of cancer in a solitary thyroid nodule is more than 10% in adults. This risk is 
more in teenagers and after 60 years of age (30% - 40%).
Sex
Nodules in men are more likely to harbour malignancy than in women.
Growth patterns
A nodule that has appeared recently or one that has undergone progressive enlargement 
over months is suspicious of malignancy. However sudden painful enlargement of a nodule is 
usually due to haemorrhage with in the nodule.
IRRADIATION
The finding of solitary thyroid nodule in an individual with a history of external irradiation31 
therapy over face, neck and chest should be regarded with a high degree of suspicion for the presence 
of malignancy.
FAMILY HISTORY
The  presence  of  a  solitory  nodule  in  a  patient  with  a  family  history  of  thyroid 
malignancy increases the risk for malignancy in the nodule.
PHYSICAL CHARACTERISTICS OF THYROID NODULE
1. Single Versus multiple:
Malignancy occurs in 10-20% of single thyroid nodules but in only 3-5% multi nodular 
goitre.
2. Consistency and fixation:
Hard consistency and the clinical impression of fixation implying invasion of adjacent 
structures also suggest malignancy. Indeed the majority of cancers occurring in single nodules 
are mobile and indistinguisable from benign lesions.
3. Recurrent nerve paralysis.
In the absence of previous neck surgery, it is virtually pathognomonic of malignancy.
4. Obstructive signs:
Clinical  evidence  of  obstruction  of  the  airway  or  of  the  great  veins  of  neck  and 
mediastinum by a solitary thyroid nodule is rare, but when present, should raise the suspicion 
of malignancy.
5. Lymphnodes
Associated  palpable  cervical  lymph adenopathy  points  strongly  to  cancer  6.  Distant 
metastasis.
CLINICO PATHOLOGICAL STAGING OF THYROID CARCINOMA; (DEGROOT) 13
I A Unilateral confined to thyroid
B. Bilateral or multifocal
II. A. Unilateral Significant cervical nodes
B. Bilateral cervical or mediastinal lymphnodes
III. Local invasion with or without positive nodes
IV. Distant metastasis
TNM classification is separate for each type of thyroid carcinoma.
Definitions of• low risk and high risk for differentiated carcinoma as per lahey clinic.
• AGES scale : Age, Grade of Tumour, Extent of disease, Size of fumor
• MACIS Scale: Metastases : Age, extent of Clearance, Invasion, Size of tumour
• AMES scale : Age, Metastases, Extent of invasion, Size of tumour.
Low risk group
• Men  of  40  years  and  younger,  women  of  50  years  and  younger  without  distant 
metastases.
• All older patients with intra thyroid papillary carcinoma or follicular carcinoma with 
minor capsular involvement, in association with tumors less than 5 cm in diameter and 
no distant metastases.
High risk group
• All patients with distant metastases
• All older patients with extra thyroid papillary carcinoma or follicular carcinoma with 
major capsular involvement and tumors  5  cm in diameter  or  larger regardless of extent of 
disease.
INVESTIGATION
Following investigation are required for evaluating a case of solitary thyroid nodule.
I. BIOCHEMICAL ASSESSMENT
Serum T3 T4 and TSH
In a hyper functioning nodule T3 and T4 will be high where as TSH will be low; but most 
patients with thyroid nodules are euthyroid. Risk of malignancy in a toxic nodule is negligible. 
Post - opTSH after thyroxine treatment should be about 0.1 micro u/ml in low risk group and < 
0.1 micro u/ml in high risk group.
Plasma Calcitonin
A  raised  level  of  plasma  calcitonin  strongly  suggests  medullary  carcinoma.  Serum 
Calcitonin can be measured after a challenge with calcium or pentagastrin; can also be used for 
post-operative follow-up in MTC.
Thyrologlobulin assay.
Mainly useful after total thyroidectomy for malignancy. A raised level is a marker of early 
recurrence.  After  total  thyroidectomy,  the  levels  should  be  <2  ng/ml  when  patient  is  on 
thyroxine and when not, it should be <3 ng/ml.
Serum levels of CEA, histaminase, CGRP and serotonin are elevated in cases of MTC. 
CEA can also be used for post op follow -  up. Serum calcium levels should be observed to rule 
out, co-existent parathyroid disorders.
24-h urinary values of VMA (Vanillyl mandelic acid), catecholamine and metanephrine 
should be done to rule out co-existent phaeochromocytoma.
These biochemical investigations were done only for few cases in this series.
II. STANDARD RADIOGRAPH
Routine chest radiogram was done for all patients planned for surgery to assess the 
respiratory system. Radiogram of neck also was taken, they showed the position of trachea, any 
compression over it and rarely calcification in the nodule
III. ISOTOPE SCANNING
With  appropriate  apparatus,  isotopically  labelled  materials  that  are  differentially 
accumulated by thyroid tissue can be detected and quantified. Radio Isotopes used are  99mTc 
Pertechnetate, 131I, 125I and 123 I
99MTC PERTECHNETATE4
Actively concentrated by the thyroid but  unlike  iodide undergoes  negligible  organic 
binding. Half life is six hours, so requires only single patient visit. Also it delivers very low 
irradiation to the thyroid tissue so it provides information about iodide-transport function of 
thyroid and not about organic binding and retention. The stay in the thyroid gland is brief and 
hence imaging done early. It is inappropriate for metastasis and substernal goitre.
Route  -  Single  IV bolus  and  imaging  performed  4-6  hour  later.  Apparatus  used  is 
scintillation camera.
125lodine:
Half life 60 days. Its low energy emission precludes scanning from deep sources such as 
sternal goitre or distant metastasis.
123Iodine:
Half life 13 hours . Radiation to the thyroid tissue is about 1% of that is delivered by 131I 
since there is absence of beta radiation. So it is the ideal isotope.
131
 Iodine:
Half life 8 days . Useful to find out functioning metastatic lesions of thyroid carcinoma.
Tc-Pentavalent -  dimercaptosuccinate Scanning (DMSA)
DMSA  Scintigraphy  scanning  has  been  shown  to  be  more  accurate  in  localising 
medullary carcinoma than the more standard techniques such as USG, CT and MRI scanning. 
Tc-Pentavalent  DMSA shows high  concentration  in  lesions  in  about  80% of  patients  with 
medullary carcinoma thyroid.
Tc99m - Sestamibi Scan, MIBG (Meta- Iodo Benzyl  -  Guanidine) Scan and PET scan 
can also be used in cases of recurrent / metastatic MTC. Tc99m -sestamibi scan also be used for 
recurrent Hurthle cell cancer.
USE OF THYROID SCAN
To define  areas  of  increased  or  decreased  function  from the  reminder  of  the  gland 
provided these areas are 1 cm or more in diameter. Better visualisation of small nodules can be 
achieved by oblique or lateral view along with antero --posterior view.
About 85% of nodules are “cold” of which 10-25% are malignant. About 5% of nodules 
are hot, of which < 1% are malignant.
Though  majority  of  cold  nodules  are  not  malignant,  lack  of  function  increases  the 
chance of developing malignancy particularly if only one nodule is present. Conversely hot 
nodules are unlikely to be malignant.
Scans performed after exogenous thyroid hormone administration (suppression scans) 
can reveal autonomous nodules.
Thyroid scans are also useful in detecting retrosternal goitres and ectopic thyroid tissue 
in the neck or ovary.
The most important use is to trace metastasis from thyroid carcinoma. (differentiated 
type), which can be detected and treated by radioactive iodine in 75% of cases. Screening can 
be facilitated by removal of all thyroid tissue which is the most compelling of all arguments in 
favour  of  total  thyroidectomy  in  differentiated  thyroid  malignancies,  except  Hurthle  cell 
carcinomas. Scanning is more sensitive to detect pulmonary micro metastases than chest x-ray 
or CT scan.
Histologically radioisotope imaging has played a major role in the work up of thyroid 
nodules, however with the advent of fine needle aspiration cytology, this role has become less 
clear. Because thyroid scans add little in determining which nodules require surgical excision, 
they should no longer be a routine part of the evaluation of a solitary thyroid nodule.
IV. Ultrasonogram of thyroid
It  is  useful  to know whether  a  nodule is  cystic  or  solid  and will  often detect  other 
impalpable nodules ; can be utilised for guided aspiration of cysts. USG can be used for follow-
up of nodules after thyroxine suppression.
V. CT scan
Useful in assessing the extent of primary tumor and neck node metastases.. Also useful 
to detect pulmonary or brains metastasis. MRI can be used to differentiate suspicious recurrent 
tumours from scar tissue.
VI. Tissue Diagnosis
• Fine needle aspiration cytology
• Core needle biposy
a. Fine Needle Aspiration Cytology (FNA C) 18
FNAC is the gold standard investigation for evaluation of solitary nodule and should be 
done for all cases. Its use in the recent years has resulted in a significant decrease in the number 
of thyroid surgeries being performed, while increasing the yield of malignant lesions of patients 
who have undergone operation.
ADVANTAGES
1.Most valuable in diagnosis
2.Safe, doesn’t require experience, and can be repeated several times.
3.Has given better selection of patients for surgical removal of nodules
4.Diagnostic accuracy -  96%.
5.No complications.
6.Is therapeutic in cases of simple thyroid cysts.
MATERIALS
1. Disposable hypodermic needle 2 1-23 size and length of 1-1.5 inches.
2. Disposable 20 cc syringe, pistol syringe holder (cameco) preferred
3. Swabs and spirit to clean.
4. 76 x 26 mm microscopic slides which are suitably numbered and labelled.
5. Koplin jar for keeping smeared slides in the fixative i.e., isopropyl alcohol.
6. Transport box
7. Laboratory requisition form with full clinical details.
8. Stain - Haematoxylin & Eosin stain or May - Grounwald Giemsa stain.
TECHNIQUE
The lesion should be  fixed between two fingers  and needle  placed in  the  centre  of 
nodule for small lesions (1-2 cms) and at periphery for larger lesions (2-4 cms). With suction 
maintained several passes (usually 4-6) of the needle are made through the tissue preferably 
with a slight change of angle during each pass.
The  plunger  is  released  to  equalise  the  pressure,  the  needle  is  withdrawn  and  the 
contents is expelled on a series of glass slides, smeared, air dried and stained.
DISADVANTAGES
1. More likelihood of insufficient material.
2. To differentiate follicular adenoma from follicular carcinoma.
b. Core Needle Biopsy:
It  produces  a  small  cylinder  of  tissue  which  is  submitted  to  histopathological 
examination.  Also  useful  in  diagnosing  follicular  carcinoma,  lymphoma  and  anaplastic 
carcinoma. This procedure has a high risk of haemorrhage and injury to adjacent structures, 
hence not routinely done.
VII. Indirect laryngyoscopy
To find out functional status of vocal cords. This was done in all patients submitted for 
surgery.
Selective venous Catheterisation
This is done for cases of suspicious recurrent / metastatic MTC. Hepatic and jugular 
veins are catheterised and a rise in calcitonin levels of sample, after pentagastrin stimulation is 
diagnostic.
GENETIC STUDIES
This is done in cases of MTC to look for RET protoncogene (Cur. 10) Point mutation 
and if positive family members 
MANAGEMENT
Management opted for solitary thyroid nodule are
1. Surgical
2. Non-Surgical
SURGICAL
Advised after cytological impression
Indications:
1. All proven malignant nodules
2. All cytologically diagnosed follicular neoplasm
3. All  lesions  exhibiting  an  atypical  pattern  but  non-diagnostic  cellular  pattern  on 
cytology.
4. All papillary adenomas
5. Cystic lesion which recurred following aspiration; > 4 cm in size; complex in nature.
6. High suspicion of malignancy on clinical grounds even if cytology suggests benign 
disease and presence of high - risk factors.
7. Hyperfunctioning nodule resulting in hyperthyroidism.
9. Obstructive symptoms, actual or potential
9. Patient anxiety
10. Cosmesis.
            The  standard  surgical  procedure  in  a  benign  single  nodule  should  be 
Hemithyroidectomy. The line of resection should be extended to the junction of the isthmus & 
the contralateral lobe.
Patients  with  toxic  nodule  may  be  treated  by  surgery.  Ideal  procedure  is 
Hemithyroidectomy.  Prior  to  surgery  patient  should  be  brought  to  euthyroid  state  with 
propranolol and carbimazole. Surgical treatment is safe, certain and without morbidity. Patients 
with toxic nodule over the age of 45 years can be treated with radioiodine.
In patients with differentiated thyroid carcinoma, there are two schools of thought,
1. HEMI THYROIDECTOMY
2. TOTAL or NEAR TOTAL THYROIDECTOMY
The Treatment Objectives in differentiated thyroid cancer are
1. Eradicate primary disease
2. Reduce the incidence of local / distant recurrence
3. Facilitate the treatment of metastasis.
4. Cure the maximum number of patients
5. Achieve all of the above with minimal morbidity
In case of minimal papillary carinoma, and minimally invasive follicular carcinoma and 
the rare encapsulated papillary carcinoma, hemi thyroidectomy is the treatment. In all other 
cases of differentiated thyroid cancers total thyroidectomy is the procedure of choice.
There are several arguments for treatment of differentiated thyroid cancer by total / near 
total thyroidectomy.
i) Multifocal disease
ii) decreased incidence of local recurrence
iii) reduced risk of anaplasia in any residual tissue.
iv)facilitation  of  diagnosing  unsuspected  metastatic  disease  by  radioactive  iodine 
scanning or treatment with I131.
V)Greater  sensitivity  of  blood  thyroglobulin  levels  to  predict  persistent  /  recurrent 
disease.
If total thyroidectomy is contemplated, it is not better than near total thyroidectomy in 
which 1 - 2 gms of normal thyroid tissue is preserved on the contralateral side to protect blood 
supply to one or more parathyroid glands.
If conservative surgery has been done TSH is suppressed by levothyroixine 0.2- 0.3 mg/
day. But TSH suppression is of doubtful value in Low risk patients.
In preparing patients for isotope scanning, T4  is stopped 8 weeks before and T3  is used 
for the first  6 weeks and stopped only 2 weeks before so that the patient will  not develop 
thyroid insufficiency. A low iodine diet is also recommended during those 2 weeks.
If lymphnodes are affected by secondary deposits in cases of papillary carcinoma or 
MTC and if a nodule of MTC is > 2 cm in size, modified neck dissection is performed on the 
ipsilateral side. Routine central neck node dissection is done for Hurthle cell carcinoma and 
MTC and in cases of involved central nodes bilateral neck dissection should be done.
If distant metastasis are found, they are treated with large doses of ‘~‘I. The alternative 
is TSH suppression with T3.
In patients with medullary carcinoma the treatment of choice is total thyroidectomy with 
central  neck  node  dissection  and  T3  replacement  therapy.  Close  relatives  are  screened  by 
estimating serum calcitonin in both basal and after pentagastrmn or calcium. If rise in serum 
calcitonin  is  observed,  prophylactic  thyroidectomy is  done.  Phaeochromocytoma should  be 
excluded  before  surgeiy,  Screening  of  family  members  with  RET  protooncogene  point 
mutation has replaced the provocation tests.
In case of anaplastic carcinoma, total thyroidectomy with modified neck dissection is 
treatment of choice but in almost all patients it is not resectable. Isthmusectomy is done to 
decompress trachea and to obtain tissue for histology. External irradiation should be given in 
all  cases for palliation of pain and dyspnea. Chemotherapy with adriamycin or adriamycin, 
chlorambucil and vincristine combination are advised.
In case of lymphoma, radical surgery is unnecessary. Once the diagnosis is established 
by biopsy, isthmusectomy is done for tracheal decompression. Lymphoma responds well to 
radio therapy.
THYROIDECTOMY PROCEDURE29
For Hemi thyroidectomy
1. Patient in supine position, neck extended with the help of a sandbag placed between the 
shoulders and rotation of the head is avoided by keeping the head on a ring.
2. A transverse collar incision is made about two finger breadth above the clavicle.
3. Elevation of  upper  & lower  flaps  in  the  plane  between platsyma and deep cervical 
fascia.
4. Vertically incise the deep cervical fascia in the midline.
5. Vertically split infrahyoid muscles.
6. Ligate and divide middle thyroid vein.
7. Ligate and divide superior thyroid pedicle
8. Inferior thyroid artery to be ligated incontinuity away from the gland.
9. The thyroid isthmus is clamped at the junction with contralateral lobe and divided.
For total tyroidectomy:
The same technique to be followed on contralateral side also. The parathyroids are 
carefully separated and left insitu.
NON SURGICAL MANAGEMENT
Thyroid surgery, even in experienced hands, is associated with definite morbidity and 
should not be undertaken lightly.
When the question of malignancy within a solitary thyroid nodule has been eliminated 
by FNAC and in the absence of obstructive symptom, it is reasonable to offer the patient a 
conservative line of management.
Review the patient after 6 months, carry out a full cervical examination and repeat the 
FNAC.  Provided  there  is  no  clinical  suspicion  of  cancer  and  the  cytology  again  is 
unequivocally benign, the individual is seen on an annual basis for re examination and further 
FNAC.
Suppressive dose of exogenous T4 to inhibit further growth of solitary thyroid nodule is 
a controversial question.
ASTWOOD6 et al, Celani et al 1990, reported successful reduction in size of nodules 
but other workers, in equally well documented reports, draw the contrary conclusion (Reverter 
et al 1992)
OBSERVATION
PREVALENCE OF SOLITARY THYROID. NODULE
TABLE :1
No. of
Thyroid
Cases
Admitted
Solitary
Thyroid
Nodules
Percentage
390 75 19.2
Solitary thyroid nodule represents thyroid pathology in about 19.2% of case.
Out of 75 patients, 65 were females and 10 were males. This gives a Male:Female ratio = 1:5. 
Solitary thyroid nodule is 5 times more common in women. In C.F.Nagori22 22 series the male 
female ratio was 1:3.5
TABLE 2
SEX DISTRIBUTION
Sex No. of
Patients
percentage
Female 65 86.7%
Male 10 13.3%
This distribution is in accordance with most of the reported series in our country and 
else where.
Considering the total number of admission of any thyroid swelling the female incidence 
is  more  partly  because  of  increased  prevalence  and  partly  because  of  increased  cosmetic 
awareness among young females.
TABLE 3
AGE DISTRIBUTION
Age In years No. of
Patients
Percentage
Upto2O 8 11
21-30 27 36
31-40 22 29
41-50 14 18
51-60 2 3
6landAbove 1 1
In this study the youngest patient was 14 years old and the oldest was 65 years old. 80% of 
solitary nodules occurred during the age between 2 1-50 years. The highest incidence of 36% was 
recorded during the third decade of life.
TABLE 4
SYMPTOMS AND SIGNS
Symptoms & Signs No. of
Patients
Percentage
Swelling Thyroid region 75 100
Pain 6 8
Toxic Symptoms 2 2.6
Dyspnoea 3 4
Dysphagia 14 18.6
Sudden Increase in size 7 9.3
Regional Palpable
Lymphnode
2 3
Hoarseness of voice 1 1.3
Hard consistency 4 5.3
All the patients had only single palpable nodule.  Toxic symptoms were present in 2 
patients. Clinical evidence of obstruction to airway or of the great veins of neck by a solitary 
thyroid nodule is rare. The presence of stridor, respiratory wheeze; engorgement of neck veins 
should be interpreted with caution and the possible existence of a second pathology with in the 
mediastinum or lungs should be considered.
Seven patients complained of a sudden increase in size; while hoarseness of voice was 
present, only in one patient. On examination the only finding was hard consistency in 4 cases.
In this study, 2 patients had regional lymphs node enlargement; which on FNAC proved 
to be secondary deposits from papillary carcinoma. 14 patients had difficulty in swallowing and 
6 patients, pain over the swelling. 3 patients had difficulty in breathing, which was mostly 
uncharacteristic, neither exertional nor positional.
TABLE 5
HORMONAL STATUS (CLINICAL)
Hormonal
Status
Total No. of
Patients
percentage
Euthyroid 73 97
Hypothyroid 2 3
Hyperthyroid - -
Most of our patients were clinically in Euthyroid status. Only 2 patients came with toxic 
symptoms.
DIAGNOSTIC WORK UP
In this study the following investigations were done in included Urine analysis,. Blood 
urea,  Blood sugar,  serum radiograph of Neck,  IDL scopy chest  radiogram and fine  needle 
aspiration cytology.
Ultrasound and CT Scan were done in few cases. Serum T3, T4 and TSH estimation were 
done in two patients admitted with toxic symptoms and confirmed toxicity. USG was done in a 
few patients  suspected  to  have  thyroid  cysts,  while  CT  scan,  was  done  in  a  patient  with 
extensive neck secondaries.
Radio  nucleotide  scanning  was  not  done  for  any  of  the  patients  due  to  the  non-
availability of the facility in our hospital.
Fine  Needle  Aspiration  Cytology  represents  a  reliable  method of  providing  a  tissue 
diagnosis and is the investigation of choice for solitary thyroid nodule.
In  this  study  FNAC  was  a  very  dependable  and  an  easy  investigation  without 
complications.
TABLE 6
FNAC REPORT
S.No FNAC Report No. of Patients
1 Follicular Neoplasm 34
2 Nodular Goitre 30
3 Papillary Carcinoma 4
4 Hashimoto’s Thyroidits 1
5 Thyroid cyst 1
6 No Report Possible 5
Amongst the FNAC reports, follicular neoplasm was the commonest to be reported with 
the inability to identify vascular/capsular invasion. Adenomatous goitre, presenting as a solitary 
nodule was next commonest eventuality. 4 cases were reported as papillary carcinoma with two 
of them showing deposits in the neck nodes. No cases of MTC / Hurthel cell carcinoma were 
reported in our series. No report was possible in 5 cases.
TABLE 7
MANAGEMENT GIVEN
S.No. Management Given No. of Patients
1 Hemithyroidectomy . 62
2 Subtotal Thyroidectomy 4
3 Near Total Thyroidectomy . 1
4 Total Thyroidectomy with block dissection 2
5 Total Thyroidectomy without block dissection 1
6 Conservative & follow up 3
7 Not willing for Surgery 2
Total 75
Out of 75 patients, 70 were submitted for surgery with below mentioned indications. 2 
patients were given conservative line of management because of Ischaemic heart disease. One 
another patient with Hashimoto’s thyroditis also was put on conservative treatment. 2 patients 
were not willing for surgery. These patients were advised regular follow up, on a half yearly 
basis for re-examinations and repeat FNAC. Repeat FNAC was done in 2 of these patients and 
were reported as benign.
Provided  there  is  no  clinical  suspicion  of  cancer  and  the  cytology is  again  unequivocally 
benign, the individual is seen on an annual basis for re-examination and further FNAC (RUSSEL).
TABLE 8
INDICATIONS FOR SURGERY
S.No Indications for Surgery No. of Patients
1 Cytology proven Malignancy 4
2 Cytology diagnosis as Follicular neoplasm 34
3 Clinical Suspicion of Malignancy with Benign
cytology
1
4 Thyroid Cyst 1
5 Patient anxiety & cosmesis 30
Total 70
This study includes two cases of solitary thyroid module with hyperthyroidism with 
benign cytology report. For these patients hemithyroidectomy was done after preparation with 
antithyroid drugs,  on the assumption that  the solitary nodule is  the overactive tissue,  since 
Radioisotope scan was not available to study the functional  status of the nodule and these 
patients had no recurrence of thyrotoxicosis.
Total thyroidectomy was done for three patients of papillary carcinoma with neck node 
dissection (FND) in two patients, whereas neck node dissection was not done in 1 case.
Near  total  thyroidectomy  was  done  for  a  patient  with  papillary  carcinoma  leaving 
behind a strip of tissue on the side other than the nodule.
Sub-total  thyroidectomy  was  done  for  4  patients  who  had  nodules  on  contralateral  lobe 
preoperatively.
Hemi-thyroidectomy, the standard surgical procedure for solitary thyroid nodule was 
done in 62 patients i.e., about 88% of patients who underwent surgery.
Surgery was done in a patient with an inconclusive FNAC report, based on clinical 
suspicion of malignancy. All resected specimens were submitted for histopathological 
examination.
TABLE 9
HISTOPATHOLOGICAL REPORT
HPE REPORT No. of Patients Percentage
CARCINOMA:
Papillary Carcinoma and Follicular
variant of papillary carcinoma 
Follicular carcinoma.
8
6
2
11.4
Follicular Adenoma 30 43
Nodular Goitre 28 40
Thyroiditis Hashimoto’s 2 2.8
Thyroid Cyst 2 2.8
Total 70
Histology proven malignancy in this series of study of solitary thyroid nodule is 11.4%., 
of  which  75% (6  cases)  were  of  papillary  carcinoma and the  rest  25% (2  cases)  were  of 
follicular  carcinoma  types.  Of  these,  four  cases  were  diagnosed  preoperatively  and  were 
offered the confirmative treatment the rest four cases were diagnosed only on HPE reporting 
and then underwent completion total thyroidectomy without neck resection. All these patients 
are under regular follow-up with suppressive doses of thyroxine.
DISCUSSION
The Incidence of thyroid cancer in patients with a solitary thyroid nodule.
Study by Kendall & Condon l96917}
Pnarras et al 1972} 11-20%
Study by Cohn F J Russel at Royal Victoria}
Hospital, BELFAST., U.K.} 13%.
Study at Coimbatore Medical College Hospital
Coimbatore 2003-2005 11.4%
This compares well with the other international studies.
In our study 40% of solitary nodule in males proved to be malignant whereas in females 
only about 6% of the solitary nodules harboured malignancy.
TABLE 10.
AGE AND SEX DISTRIBUTION OF BENIGN AND MALIGNANT
NODULE
Age in
Years
Males Females
Benign Malignant Total Benign Malignant Total
Upto 20 1 1 2 10 2 12
21-30 1 0 1 22 0 22
3 1-40 1 0 1 15 1 16
41-50 2 2 4 6 0 6
51-60 1 1 2 2 0 2
61 and above 0 0 0 1 1 2
Total 6 4 10 56 4 60
According  to  Matheson  1986,  the  malignant  potential  of  a  nodule  in  a  man  is 
approximately three times that for a women of comparable age and in our study, the risk has 
been almost six times.
In males 75% of cancer occurred in more than 40 years age group.
Malignancy is more likely in a nodule in a child or a teenager or when a goitre develops 
in a patient aged 60 years or above (Hamming et al 1990, Caruso and Mazzaferri9 1991)
50% of thyroid cancers occurred in individuals under 40 years of age and of them 75% 
is papillary carcinoma. Fravenhofer37 et al 1970 in his study of 125 cases of thyroid cancer 
found  that  80%  of  thyroid  cancers  in  individuals  under  40  years  of  age  was  papillary 
carcinoma.
TABLE 11
HISTOLOGICALLY PROVEN MALIGNANCY
TYPE No. OF
PATIENTS
PERCENTAG
E
PAPILLARY CARCINOMA 6 75
FOLLICULAR
CARCINOMA
2 25
MEDULLARY
CARCINOMA
0 0
No medullary carcinoma, anaplastic carcinoma and lymphoma was reported in our 
series.
The relative incidence of primary malignant tumours in our series is almost in 
accordance with most of the reported series (DUNHILL36).
In our study, 50% of the cases, all of them males, developed malignancy after 40 years, 
whereas in females, 75% of cases were younger than 40 years.
COMPARISON  OF  PRE  OPERATIVE  FNAC  WITH  POST  OPERATIVE 
HISTOPATHOLOGICAL EXAMINATION:
Out of 70 cases operated 5 had different histopathology reports as compared to FNAC. 
If both FNAC & histopathology are benign or malignant they are considered true positive.
4  cytologicaly  benign  lesions  were  reported  as  malignant  on  histopathological 
examination. So FNAC was false negative in these cases.
TABLE 12
ACCURACY RATE OF FNAC
Result True
Positive case
False
Negative
False 
Positive
Total
No. of Cases 66 4 0 70
Percentage 94 6 0
In comparison on overall accuracy rate greater than 94% was achieved in the cytological 
diagnosis of a solitary nodule.
CANCER RISK IN FOLLICULAR NEOPLA’SM
The cytological appearances of follicular adenoma and follicular carcinoma are very 
similar. So a cytological diagnosis of follicular neoplasm is only possible, and confirmation of 
diagnosis  of  follicular  carcinoma  depends  upon  the  visualisation  of  capillary  &  Vascular 
invasion in histopathological examination.
Although the Cancer risk is only 20%, CFJ RUSSEL, in common with others advises 
surgical resection of all solitary thyroid nodules reported as follicular neoplasm cytologically.
In this study, 34 cases were diagnosed as folhicular neoplasm cytologically and of these 
four were histologically malignant - .12% cancer risk.
SURGICAL PROCEDURES
CARCINOMA
We  have  done  total  thyroidectomy  for  three  patients  with  or  without  neck  node. 
dissection. All three were papillary carcinoma. Near total thyroidectomy was done for a case, 
also of papillary carcinoma.
Total Thyroidectomy is considered not only as a measure to reduce the recurrence rate 
of differentiated carcinoma but also as a means to prevent development of a highly malignant 
undifferentiated lesion. The percentage of radio iodine pick up can be increased several fold 
after total thyroidectomy and it also increases the sensitivity of thyroglobin as a post operative 
marker of residual / recurrent disease.
DISADVANTAGE
The risk of permanent hypoparathyroidsm or recurrent laryngeal nerve damage is high.
We have done near total thyroidectomy for one patient, a case of cytological proven 
papillary carcinoma, which was a small lesion (1.5 cm).
Near  total  thyroidectomy  means  leaving  a  fringe  of  thyroid  tissue  to  preserve 
parathyroid.
Indications for near total thyroidectomy includes smaller lesions and better prognostic 
variants of papillary carcinoma thyroid.
Advantages of near total thyroidectomy are
1. Lesser incidence of permanent or transient hypo parathyroidism
2. Lesser incidence of recurrent laryngeal nerve palsy
Disadvantage of near total thyroidectomy are
1. Follow up is difficult
2. Remaining thyroid tissue has to ablated for control of metastasis.
Out of the four false negative patients (cytologically benign) all were treated with hemi- 
thyroidectomy. All these patients were taken up for completion thyroidectomy because they fell 
into the high risk group and they had an uneventful post operative period and follow up.
Ipsilateral  lobectomy  with  isthmusectomy  is  what  is  required  in  all  patients  with 
differentiated carcinoma of favourable prognosis as given in AGES scoring system (HAY ID). 
The  favourable  prognostic  factors  are  lesion  less  than  2  cm  without  cervical  or  distant 
metastasis, age less than 40 years in males and less than 45 years in females.
So,  the  above  patients  were  advised  completion  surgery  with  suppresive  dose  of 
thyroxine and regular follow-up.
The indications for isotope scanning after operation for differentiated cancer are.
1. Unresectable local recurrence
2. Metastatic disease
3. High risk patients and
4. Those with increase in serum Thyroglobulin level.
MALIGNANCY IN A TOXIC NODULE
Majority of cancers arise in hypo or cold thyroid nodules (ALDERSON et al 1976 COX 
et al 1991). The possibility of malignancy occurring with in a hot nodule is rare.
In our study, two patients with clinical toxicity were reported as follicular neoplasm 
cytologically and as folhicular adenoma histopathologically.
ADENOMA
Out of the 70 cases operated 30 cases were histolopathologically reported as adenoma. 
Most of them were macrofollicular adenoma. Hemithyroidectomy was done for all the patients.
Adenoma thyroid commonly occurred in the 3rd decade in this series of study.
NODULAR GOITRE
40% of operated cases were diagnosed as nodular goitre, hemithyroidectomy was done 
for most of them.
4 patients had nodules in the contra lateral lobe also, which were revealed peroperatively, hence 
sub-total thyroidectomy was done.
TABLE 13
ADENOMA AND NODULAR GOITRE - HISTORICAL COMPARISON
Adenoma Nodular Goitre
Usually single Usually multiple nodules
Completely encapsulated Partly encapsulated or unencapsulated
Compress the surrounding thyroid 
tissue
Doesn’t compress surrounding thyroid 
tissue.
Compared of fairly uniform follicles 
smaller than rest of thyroid tissue
Heterogenous appearance often with 
larger follicles.
Degenerative changes uncommon Hyperplastic follicles with focal 
haemorrhages, scarring, calcification 
and micro cyst formation.
OUT COME OF THERAPY
Complications
Out  of  the  70  patients  operated,  two  developed  features  of  hypocalcaemia  in  the 
immediate post operative period and were revived with intravenous, calcium gluconate and 
with no need for oral calcium supplementation.
Two patients had sluggish movement of left vocal cord after total thyroidectomy and 
improved later.
Seven patients had post operative wound infection. We had no mortality during this 
study.
Table 14
COMPARISION
Study by Cohn FJ Russel FRCS At Royal
Victoria Hospital Belfast .U.K.
61 patients operated for solitary thyroid
nodule
Study at Coimbatore
Medical College Hospital
Coimbatore
70 patients operated for
solitary thyroid nodule
FNAC
Pathological
Diagnosis
Number of
Patients
.
Percentage Number of
Patients
Percentage
Nodular
Goitre
30 49 28 40
Follicular
Adenoma
19 31 30 43
Malignancy 8 13 8 11.4
Hashimotos 3 5 2 2.8
Dequervains 1 2 - -
Simple cyst - - 2 2.8
CONCLUSIONS
1. FNAC is the gold standard for evaluation of Solitary Thyroid Nodule with an accuracy of 
94% in our study.
2. 11.4 percentage of Solitary Thyroid Nodule were Malignant
3. Solitary Thyroid Nodule in males have more malignancy risk than female.
4. Suspect malignancy at extremes of age. Malignancy potential of Solitary Thyroid Nodule 
after 6th decade is 50%.
5. 50 percentage of thyroid cancer occurred in patients under 40 years of age, of them 75% 
were papillary carcinoma.
6. A selective surgical policy should be practised to resect Solitary Thyroid Nodule
7. Hemi thyroidectomy is the minimum, surgical procedure for single nodule.
8. Cancer risk in follicular neoplasm is 12%
9. Patient being submitted to Thyroidectomy should be counselled preoperatiely with regard 
to the risk of recurrent Laryngeal nerve paralysis.
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